Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Nov 11

PMID 34760696

Citations 31

Authors

Kavitha Unnikrishnan

Lynda Velutheril Thomas

Ram Mohan Ram Kumar

Affiliations

Soon will be listed here.

Abstract

The lack of traditional cancer treatments has resulted in an increased need for new clinical techniques. Standard two-dimensional (2D) models used to validate drug efficacy and screening have a low - translation potential. Recreating the tumor microenvironment at the three-dimensional (3D) level is essential to resolve these limitations in the 2D culture and improve therapy results. The physical and mechanical environments of 3D culture allow cancer cells to expand in a heterogeneous manner, adopt different phenotypes, gene and protein profiles, and develop metastatic potential and drug resistance similar to human tumors. The current application of 3D scaffold culture systems based on synthetic polymers or selected extracellular matrix components promotes signalling, survival, and cancer cell proliferation. This review will focus on the recent advancement of numerous 3D-based scaffold models for cancer tissue engineering, which will increase the predictive ability of preclinical studies and significantly improve clinical translation.

Citing Articles

Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review).

Isinelli G, Failla S, Plebani R, Prete A Med Int (Lond). 2025; 5(2):13.

PMID: 39790707 PMC: 11707505. DOI: 10.3892/mi.2024.212.

Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.

Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C Heliyon. 2024; 10(23):e40596.

PMID: 39687122 PMC: 11647801. DOI: 10.1016/j.heliyon.2024.e40596.

culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.

Svozilova H, Vojtova L, Matulova J, Bruknerova J, Polakova V, Radova L PeerJ. 2024; 12:e18637.

PMID: 39655330 PMC: 11627079. DOI: 10.7717/peerj.18637.

Modeling intratumor heterogeneity in breast cancer.

McDonough E, Barroso M, Ginty F, Corr D Biofabrication. 2024; 17(1.

PMID: 39642392 PMC: 11740194. DOI: 10.1088/1758-5090/ad9b50.

Three-Dimensional Culture of Glioblastoma Cells Using a Tissueoid Cell Culture System.

Okamoto N, Taniura N, Nakayama T, Tanaka E, Kageyama Y, Noujima M Acta Histochem Cytochem. 2024; 57(5):149-155.

PMID: 39552931 PMC: 11565224. DOI: 10.1267/ahc.24-00043.

References

Monteiro M, Gaspar V, Ferreira L, Mano J . Hydrogel 3D in vitro tumor models for screening cell aggregation mediated drug response. Biomater Sci. 2020; 8(7):1855-1864. DOI: 10.1039/c9bm02075f. View

Polonio-Alcala E, Rabionet M, Gallardo X, Angelats D, Ciurana J, Ruiz-Martinez S . PLA Electrospun Scaffolds for Three-Dimensional Triple-Negative Breast Cancer Cell Culture. Polymers (Basel). 2019; 11(5). PMC: 6572693. DOI: 10.3390/polym11050916. View

Zhao Z, Vizetto-Duarte C, Moay Z, Setyawati M, Rakshit M, Kathawala M . Composite Hydrogels in Three-Dimensional Models. Front Bioeng Biotechnol. 2020; 8:611. PMC: 7325910. DOI: 10.3389/fbioe.2020.00611. View

Zhu M, Wang Y, Ferracci G, Zheng J, Cho N, Lee B . Gelatin methacryloyl and its hydrogels with an exceptional degree of controllability and batch-to-batch consistency. Sci Rep. 2019; 9(1):6863. PMC: 6499775. DOI: 10.1038/s41598-019-42186-x. View

Song H, Cai G, Liang J, Ao D, Wang H, Yang Z . Three-dimensional culture and clinical drug responses of a highly metastatic human ovarian cancer HO-8910PM cells in nanofibrous microenvironments of three hydrogel biomaterials. J Nanobiotechnology. 2020; 18(1):90. PMC: 7291456. DOI: 10.1186/s12951-020-00646-x. View

Duarte Campos D, Marquez A, OSeanain C, Fischer H, Blaeser A, Vogt M . Exploring Cancer Cell Behavior In Vitro in Three-Dimensional Multicellular Bioprintable Collagen-Based Hydrogels. Cancers (Basel). 2019; 11(2). PMC: 6406373. DOI: 10.3390/cancers11020180. View

Efraim Y, Schoen B, Zahran S, Davidov T, Vasilyev G, Baruch L . 3D Structure and Processing Methods Direct the Biological Attributes of ECM-Based Cardiac Scaffolds. Sci Rep. 2019; 9(1):5578. PMC: 6447624. DOI: 10.1038/s41598-019-41831-9. View

Lu W, Zhang L, Wu C, Liu Z, Lei G, Liu J . Development of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineering. PLoS One. 2014; 9(7):e103672. PMC: 4114977. DOI: 10.1371/journal.pone.0103672. View

Wang X, Zhang X, Dai X, Wang X, Li X, Diao J . Tumor-like lung cancer model based on 3D bioprinting. 3 Biotech. 2018; 8(12):501. PMC: 6258569. DOI: 10.1007/s13205-018-1519-1. View

10.

Liu G, Wang B, Li S, Jin Q, Dai Y . Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro. J Cell Physiol. 2018; 234(6):9447-9456. DOI: 10.1002/jcp.27630. View

11.

Dhamecha D, Le D, Movsas R, Gonsalves A, Menon J . Porous Polymeric Microspheres With Controllable Pore Diameters for Tissue Engineered Lung Tumor Model Development. Front Bioeng Biotechnol. 2020; 8:799. PMC: 7365955. DOI: 10.3389/fbioe.2020.00799. View

12.

Guo J, Zhao C, Yao R, Sui A, Sun L, Liu X . 3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression. Exp Ther Med. 2019; 17(3):1593-1600. PMC: 6364197. DOI: 10.3892/etm.2019.7153. View

13.

DAngelo E, Natarajan D, Sensi F, Ajayi O, Fassan M, Mammano E . Patient-Derived Scaffolds of Colorectal Cancer Metastases as an Organotypic 3D Model of the Liver Metastatic Microenvironment. Cancers (Basel). 2020; 12(2). PMC: 7072130. DOI: 10.3390/cancers12020364. View

14.

Parkinson G, Salerno S, Ranji P, Hakansson J, Bogestal Y, Wettergren Y . Patient-derived scaffolds as a model of colorectal cancer. Cancer Med. 2020; 10(3):867-882. PMC: 7897946. DOI: 10.1002/cam4.3668. View

15.

Kuriakose A, Hu W, Nguyen K, Menon J . Scaffold-based lung tumor culture on porous PLGA microparticle substrates. PLoS One. 2019; 14(5):e0217640. PMC: 6544352. DOI: 10.1371/journal.pone.0217640. View

16.

Polonio-Alcala E, Rabionet M, Guerra A, Yeste M, Ciurana J, Puig T . Screening of Additive Manufactured Scaffolds Designs for Triple Negative Breast Cancer 3D Cell Culture and Stem-Like Expansion. Int J Mol Sci. 2018; 19(10). PMC: 6213377. DOI: 10.3390/ijms19103148. View

17.

Gustafsson A, Garre E, Leiva M, Salerno S, Stahlberg A, Landberg G . Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer. Sci Rep. 2021; 11(1):13334. PMC: 8233392. DOI: 10.1038/s41598-021-92724-9. View

18.

Tornin J, Villasante A, Sole-Marti X, Ginebra M, Canal C . Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties. Free Radic Biol Med. 2021; 164:107-118. PMC: 7921834. DOI: 10.1016/j.freeradbiomed.2020.12.437. View

19.

Boateng S, Lateef S, Mosley W, Hartman T, Hanley L, Russell B . RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes. Am J Physiol Cell Physiol. 2004; 288(1):C30-8. DOI: 10.1152/ajpcell.00199.2004. View

20.

Landberg G, Fitzpatrick P, Isakson P, Jonasson E, Karlsson J, Larsson E . Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment. Biomaterials. 2020; 235:119705. DOI: 10.1016/j.biomaterials.2019.119705. View